Omprakash Shriwas

627 total citations
12 papers, 477 citations indexed

About

Omprakash Shriwas is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Omprakash Shriwas has authored 12 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Omprakash Shriwas's work include Cancer-related gene regulation (4 papers), RNA modifications and cancer (3 papers) and Cancer-related Molecular Pathways (3 papers). Omprakash Shriwas is often cited by papers focused on Cancer-related gene regulation (4 papers), RNA modifications and cancer (3 papers) and Cancer-related Molecular Pathways (3 papers). Omprakash Shriwas collaborates with scholars based in India and United States. Omprakash Shriwas's co-authors include Rupesh Dash, Rachna Rath, Sabindra K. Samal, Dillip Kumar Muduly, Saroj Majumdar, Santanu Maji, Paul B. Fisher, Maurizio Pellecchia, Luni Emdad and Swadesh K. Das and has published in prestigious journals such as Oncogene, The FASEB Journal and British Journal of Cancer.

In The Last Decade

Omprakash Shriwas

12 papers receiving 474 citations

Peers

Omprakash Shriwas

ONCOL

IMMUN

PRM

Sabindra K. Samal India

Jia-Rong Huang China

Catia Mio Italy

Alok Mishra India

Hua Guan China

Huiling Zhou China

Z. Peter Wang China

Aditi Sharma United States

Lanya Li China

Size Chen China

Sabindra K. Samal India

Omprakash Shriwas

369 ×1.0

121 ×0.8

120 ×0.9

ONCOL

40 ×0.9

IMMUN

27 ×0.7

PRM

Citations per year, relative to Omprakash Shriwas Omprakash Shriwas (= 1×) peers Sabindra K. Samal

Countries citing papers authored by Omprakash Shriwas

Since Specialization

Citations

This map shows the geographic impact of Omprakash Shriwas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omprakash Shriwas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omprakash Shriwas more than expected).

Fields of papers citing papers by Omprakash Shriwas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omprakash Shriwas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omprakash Shriwas. The network helps show where Omprakash Shriwas may publish in the future.

Co-authorship network of co-authors of Omprakash Shriwas

This figure shows the co-authorship network connecting the top 25 collaborators of Omprakash Shriwas. A scholar is included among the top collaborators of Omprakash Shriwas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omprakash Shriwas. Omprakash Shriwas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Xu, Meng, Ling Lin, Omprakash Shriwas, et al.. (2023). Heat shock factor 1 (HSF1) specifically potentiates c-MYC-mediated transcription independently of the canonical heat shock response. Cell Reports. 42(6). 112557–112557. 7 indexed citations

Shriwas, Omprakash, Rachna Rath, Mahesh Sultania, et al.. (2022). CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis. Oncogene. 41(45). 4929–4940. 13 indexed citations

Shriwas, Omprakash, Arup Ghosh, Rachna Rath, et al.. (2022). CMTM6 attenuates cisplatin‐induced cell death in OSCC by regulating AKT/c‐Myc ‐driven ribosome biogenesis. The FASEB Journal. 36(10). e22566–e22566. 10 indexed citations

Shriwas, Omprakash, et al.. (2021). The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy. Frontiers in Oncology. 10. 612337–612337. 55 indexed citations

Shriwas, Omprakash, Rakesh Arya, Sugandh Kumar, et al.. (2021). Correction: RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway. British Journal of Cancer. 124(12). 2039–2039. 1 indexed citations

Shriwas, Omprakash, Arup Ghosh, Shuchi Smita, et al.. (2021). CMTM6 drives cisplatin resistance by regulating Wnt signaling through ENO-1/AKT/GSK3β axis. JCI Insight. 6(4). 41 indexed citations

Shriwas, Omprakash, Rakesh Arya, Sugandh Kumar, et al.. (2021). RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway. British Journal of Cancer. 124(12). 2004–2016. 20 indexed citations

Sen, Kaushik, Arup Ghosh, Abdul Ahad, et al.. (2021). Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases. Frontiers in Immunology. 12. 733539–733539. 7 indexed citations

Kumari, Anuradha, Omprakash Shriwas, Manas Kumar Santra, et al.. (2021). Microtubule‐targeting agents impair kinesin‐2‐dependent nuclear transport of β‐catenin: Evidence of inhibition of Wnt/β‐catenin signaling as an important antitumor mechanism of microtubule‐targeting agents. The FASEB Journal. 35(4). e21539–e21539. 8 indexed citations

10.

Shriwas, Omprakash, Sabindra K. Samal, Rachna Rath, et al.. (2020). DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG. APOPTOSIS. 25(3-4). 233–246. 117 indexed citations

11.

Maji, Santanu, Omprakash Shriwas, Sabindra K. Samal, et al.. (2018). STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma. Carcinogenesis. 40(1). 173–183. 34 indexed citations

12.

Maji, Santanu, Sabindra K. Samal, Omprakash Shriwas, et al.. (2017). Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer. Advances in cancer research. 137. 37–75. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact